BRCA2 and adenocarcinoma: Carriers of BRCA1 and BRCA2 P/LP variants accounted for 0.79% and 0.60% of 1017 lung cancer patients with adenocarcinoma or squamous cell carcinoma, respectively, in the TCGA cohort.15